Daiwa Securities Group Inc. reduced its stake in Steris PLC (NYSE:STE) by 23.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 77,872 shares of the medical equipment provider’s stock after selling 23,528 shares during the quarter. Daiwa Securities Group Inc. owned about 0.09% of Steris worth $11,252,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of STE. Ropes Wealth Advisors LLC acquired a new position in Steris in the second quarter valued at approximately $26,000. Squar Milner Financial Services LLC lifted its stake in Steris by 225.9% in the third quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 122 shares during the period. Evolution Wealth Advisors LLC acquired a new position in Steris in the second quarter valued at approximately $27,000. Quest Capital Management Inc. ADV acquired a new position in Steris in the third quarter valued at approximately $26,000. Finally, Krane Funds Advisors LLC acquired a new position in Steris in the second quarter valued at approximately $27,000. 88.11% of the stock is currently owned by institutional investors.
In related news, VP John Adam Zangerle sold 1,000 shares of the company’s stock in a transaction on Friday, October 4th. The stock was sold at an average price of $142.15, for a total transaction of $142,150.00. Also, VP Renato Tamaro sold 2,065 shares of the company’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $153.15, for a total value of $316,254.75. The disclosure for this sale can be found here. Corporate insiders own 2.36% of the company’s stock.
Separately, ValuEngine lowered Steris from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $148.20.
Shares of NYSE STE traded up $0.65 during midday trading on Friday, hitting $145.84. 282,472 shares of the stock traded hands, compared to its average volume of 445,755. The company has a market cap of $12.38 billion, a PE ratio of 29.82 and a beta of 0.88. Steris PLC has a one year low of $99.14 and a one year high of $156.66. The business has a 50 day moving average price of $142.14 and a two-hundred day moving average price of $143.00. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.87 and a current ratio of 2.41.
Steris (NYSE:STE) last released its quarterly earnings data on Monday, November 4th. The medical equipment provider reported $1.32 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.26 by $0.06. The firm had revenue of $736.84 million during the quarter, compared to the consensus estimate of $717.79 million. Steris had a return on equity of 14.28% and a net margin of 11.59%. The company’s quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.10 earnings per share. As a group, equities research analysts forecast that Steris PLC will post 5.61 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Tuesday, November 26th will be issued a dividend of $0.37 per share. The ex-dividend date is Monday, November 25th. This represents a $1.48 annualized dividend and a yield of 1.01%. Steris’s dividend payout ratio (DPR) is currently 30.27%.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Read More: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.